APA (7th ed.) Citation

Z, L., Y, A., J, H., Z, Z., K, J., K, C., & F, S. Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

Z, Liang, An Y, He J, Zhu Z, Jiang K, Chen K, and Sun F. Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer. Dove Medical Press.

MLA (9th ed.) Citation

Z, Liang, et al. Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer. Dove Medical Press.